These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 23144196

  • 1. Central nervous system recurrence of systemic lymphoma in the era of stem cell transplantation--an International Primary Central Nervous System Lymphoma Study Group project.
    Bromberg JE, Doorduijn JK, Illerhaus G, Jahnke K, Korfel A, Fischer L, Fritsch K, Kuittinen O, Issa S, van Montfort C, van den Bent MJ.
    Haematologica; 2013 May; 98(5):808-13. PubMed ID: 23144196
    [Abstract] [Full Text] [Related]

  • 2. Concomitant systemic and central nervous system non-Hodgkin lymphoma: the role of consolidation in terms of high dose therapy and autologous stem cell transplantation. A 60-case retrospective study from LYSA and the LOC network.
    Damaj G, Ivanoff S, Coso D, Ysaebert L, Choquet S, Houillier C, Parcelier A, Abarah W, Marjanovic Z, Gressin R, Garidi R, Diouf M, Gac AC, Dupuis J, Troussard X, Morschhauseur F, Ghesquières H, Soussain C, LYSA and LOC network, France.
    Haematologica; 2015 Sep; 100(9):1199-206. PubMed ID: 26185174
    [Abstract] [Full Text] [Related]

  • 3. Prognosis of patients with primary central nervous system lymphoma after high-dose chemotherapy followed by autologous stem cell transplantation.
    Schorb E, Kasenda B, Atta J, Kaun S, Morgner A, Hess G, Elter T, von Bubnoff N, Dreyling M, Ringhoffer M, Krause SW, Derigs G, Klimm B, Niemann D, Fritsch K, Finke J, Illerhaus G.
    Haematologica; 2013 May; 98(5):765-70. PubMed ID: 23300179
    [Abstract] [Full Text] [Related]

  • 4. High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma.
    Alvarnas JC, Negrin RS, Horning SJ, Hu WW, Long GD, Schriber JR, Stockerl-Goldstein K, Tierney K, Wong R, Blume KG, Chao NJ.
    Biol Blood Marrow Transplant; 2000 May; 6(3A):352-8. PubMed ID: 10905773
    [Abstract] [Full Text] [Related]

  • 5. Treatment of primary CNS lymphoma (PCNSL) following successful treatment of systemic non-Hodgkin's lymphoma (NHL): a case series.
    Chamberlain MC.
    J Neurooncol; 2013 May; 113(1):27-32. PubMed ID: 23456654
    [Abstract] [Full Text] [Related]

  • 6. High dose chemotherapy and autologous stem cell transplantation for poor risk and recurrent non-Hodgkin's lymphoma: a single-center experience of 50 patients.
    Shim BY, Lee MA, Byun JH, Roh SY, Song CW, Park JN, Lee JW, Min WS, Hong YS, Kim CC.
    Korean J Intern Med; 2004 Jun; 19(2):114-20. PubMed ID: 15366643
    [Abstract] [Full Text] [Related]

  • 7. Management and prognosis of 66 patients with B-cell non-Hodgkin lymphoma presenting with initial spinal cord compression: a French retrospective multicenter study.
    Fleury I, Amorim S, Mounier N, Coiffier B, Dupuis J, Tilly H, Mazari MA, Filliatre L, Brière J, Brice P, de Kerviler E, Thieblemont C.
    Leuk Lymphoma; 2015 Jul; 56(7):2025-31. PubMed ID: 25347431
    [Abstract] [Full Text] [Related]

  • 8. Treatment of secondary central nervous system lymphoma with intrathecal rituximab, high-dose methotrexate, and R-DHAP followed by autologous stem cell transplantation: results of the HOVON 80 phase 2 study.
    Doorduijn JK, van Imhoff GW, van der Holt B, Schouten HC, Schaafsma MR, MacKenzie MA, Baars JW, Kersten MJ, Lugtenburg PJ, van den Bent MJ, Enting RH, Spoelstra FM, Poortmans P, Bromberg JEC.
    Hematol Oncol; 2017 Dec; 35(4):497-503. PubMed ID: 27530779
    [Abstract] [Full Text] [Related]

  • 9. Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network.
    Langner-Lemercier S, Houillier C, Soussain C, Ghesquières H, Chinot O, Taillandier L, Soubeyran P, Lamy T, Morschhauser F, Benouaich-Amiel A, Ahle G, Moles-Moreau MP, Moluçon-Chabrot C, Bourquard P, Damaj G, Jardin F, Larrieu D, Gyan E, Gressin R, Jaccard A, Choquet S, Brion A, Casasnovas O, Colin P, Reman O, Tempescul A, Marolleau JP, Fabbro M, Naudet F, Hoang-Xuan K, Houot R.
    Neuro Oncol; 2016 Sep; 18(9):1297-303. PubMed ID: 26951382
    [Abstract] [Full Text] [Related]

  • 10. Improved survival outcomes despite older age at diagnosis: an era-by-era analysis of patients with primary central nervous system lymphoma treated at a single referral centre in the United Kingdom.
    Kaji FA, Martinez-Calle N, Bishton MJ, Figueroa R, Adlington J, O'Donoghue M, Smith S, Byrne P, Paine S, Sovani V, Auer D, James E, Bessell EM, Grainge MJ, Fox CP.
    Br J Haematol; 2021 Nov; 195(4):561-570. PubMed ID: 34368948
    [Abstract] [Full Text] [Related]

  • 11. Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report.
    Grimm SA, Pulido JS, Jahnke K, Schiff D, Hall AJ, Shenkier TN, Siegal T, Doolittle ND, Batchelor T, Herrlinger U, Neuwelt EA, Laperriere N, Chamberlain MC, Blay JY, Ferreri AJ, Omuro AM, Thiel E, Abrey LE.
    Ann Oncol; 2007 Nov; 18(11):1851-5. PubMed ID: 17804469
    [Abstract] [Full Text] [Related]

  • 12. Primary breast diffuse large B-cell lymphoma characterized by CNS relapse and successful hematopoietic stem cell transplantation salvage therapy.
    Chan CY, Ou CW, Chang H, Kuo MC, Lin TL, Hung YS, Wu JH, Shih LY, Kao HW.
    J Formos Med Assoc; 2024 Oct; 123(10):1078-1086. PubMed ID: 38296697
    [Abstract] [Full Text] [Related]

  • 13. High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma--a randomized phase III trial (MATRix).
    Schorb E, Finke J, Ferreri AJ, Ihorst G, Mikesch K, Kasenda B, Fritsch K, Fricker H, Burger E, Grishina O, Valk E, Zucca E, Illerhaus G.
    BMC Cancer; 2016 Apr 21; 16():282. PubMed ID: 27098429
    [Abstract] [Full Text] [Related]

  • 14. Autologous stem-cell transplantation for poor-risk and relapsed intermediate- and high-grade non-Hodgkin's lymphoma.
    Nademanee A, Molina A, Dagis A, Snyder DS, O'Donnell MR, Parker P, Stein A, Smith E, Planas I, Kashyap A, Spielberger R, Fung H, Krishnan A, Bhatia R, Wong KK, Somlo G, Margolin K, Chow W, Sniecinski I, Vora N, Slovak M, Niland JC, Forman SJ.
    Clin Lymphoma; 2000 Jun 21; 1(1):46-54. PubMed ID: 11707813
    [Abstract] [Full Text] [Related]

  • 15. High-Dose Chemotherapy with Autologous Stem Cell Transplantation in Primary Central Nervous System Lymphoma: Data From the Japan Society for Hematopoietic Cell Transplantation Registry.
    Kondo E, Ikeda T, Izutsu K, Chihara D, Shimizu-Koresawa R, Fujii N, Sakai T, Kondo T, Kubo K, Kato Y, Akasaka T, Fukuda T, Ichinohe T, Atsuta Y, Suzumiya J, Suzuki R, Adult Lymphoma Working Group of the Japan Society for Hematopoietic Cell Transplantation.
    Biol Blood Marrow Transplant; 2019 May 21; 25(5):899-905. PubMed ID: 30664936
    [Abstract] [Full Text] [Related]

  • 16. R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma.
    Omuro A, Correa DD, DeAngelis LM, Moskowitz CH, Matasar MJ, Kaley TJ, Gavrilovic IT, Nolan C, Pentsova E, Grommes CC, Panageas KS, Baser RE, Faivre G, Abrey LE, Sauter CS.
    Blood; 2015 Feb 26; 125(9):1403-10. PubMed ID: 25568347
    [Abstract] [Full Text] [Related]

  • 17. Therapeutic management of refractory or relapsed primary central nervous system lymphomas.
    Reni M, Ferreri AJ.
    Ann Hematol; 2001 Feb 26; 80 Suppl 3():B113-7. PubMed ID: 11757691
    [Abstract] [Full Text] [Related]

  • 18. Pilot study of gamma-knife surgery-incorporated systemic chemotherapy omitting whole brain radiotherapy for the treatment of elderly primary central nervous system lymphoma patients with poor prognostic scores.
    Cho J, Kim J, Ryu HJ, Roh HG, Chung HW, Koh YC, Lee MH, Ko YH, Kim SY.
    Med Oncol; 2014 Mar 26; 31(3):863. PubMed ID: 24496562
    [Abstract] [Full Text] [Related]

  • 19. Intensive chemotherapy with thiotepa, busulfan and cyclophosphamide and hematopoietic stem cell rescue in relapsed or refractory primary central nervous system lymphoma and intraocular lymphoma: a retrospective study of 79 cases.
    Soussain C, Choquet S, Fourme E, Delgadillo D, Bouabdallah K, Ghesquières H, Damaj G, Dupriez B, Vargaftig J, Gonzalez A, Houillier C, Taillandier L, Hoang-Xuan K, Leblond V.
    Haematologica; 2012 Nov 26; 97(11):1751-6. PubMed ID: 22581000
    [Abstract] [Full Text] [Related]

  • 20. Autologous haematopoietic cell transplantation for non-Hodgkin lymphoma with secondary CNS involvement.
    Maziarz RT, Wang Z, Zhang MJ, Bolwell BJ, Chen AI, Fenske TS, Freytes CO, Gale RP, Gibson J, Hayes-Lattin BM, Holmberg L, Inwards DJ, Isola LM, Khoury HJ, Lewis VA, Maharaj D, Munker R, Phillips GL, Rizzieri DA, Rowlings PA, Saber W, Satwani P, Waller EK, Maloney DG, Montoto S, Laport GG, Vose JM, Lazarus HM, Hari PN.
    Br J Haematol; 2013 Sep 26; 162(5):648-56. PubMed ID: 23829536
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.